Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger) > Dusty

<< Previous

Bullboard Posts

Next >>

Post by Stutterson Apr 22, 2022 1:33am

267 Views

Post# 34622804

Dusty

i had similar selling confusion. My sales never registered Throughout the day. Was wondering if an institution bought my buy as their own somehow ...or it is canadian stocks and pure manipulation , only apparent on low volume. I had part of a 18000 bid part fill 2 months ago and then the rest of my bid would not fill for 2 weeks , as other bids filled for same price. Mine part filled , meaning i was next in cue for rest to fill. NOT SO THOUGH.

<< Previous

Bullboard Posts

Next >>

FE Battery Metals begins 2024 winter drill program